PFE

#99
Pfizer, Inc. Common Stock
25.9 7 USD
-0.35%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
25.95
26.22
Year Range
23.06
28.75
Daily Change
-0.35%
Monthly Change
-1.59%
6 month change
+0.82%
Year Change
+10.51%
Previous Close
26.0 6
Open
26.1 9
Low
25.9 5
High
26.2 2
Volume
2 117
Open full chart Full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 148.01 B
  • Employee 75 K
  • Founded N/A
  • CEO Albert Bourla
  • Website www.pfizer.com
  • Headquarter Delaware, United States
  • FIGI BBG000BR2B91
  • Industry Drug Manufacturers—General
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
21.2
Price to sales ratio
2.51
Dividends per share
—
Dividend yield %
9.29

Pfizer, Inc. Common Stock

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2024, 61% of the company's revenues came from the United States, 4% came from China, and 35% came from other countries. The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000.

News